Your browser doesn't support javascript.
loading
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.
Bulian, Pietro; Bomben, Riccardo; Bo, Michele Dal; Zucchetto, Antonella; Rossi, Francesca Maria; Degan, Massimo; Pozzo, Federico; Bittolo, Tamara; Bravin, Vanessa; D'Agaro, Tiziana; Cerri, Michaela; Chiarenza, Annalisa; Chaffee, Kari G; Condoluci, Adalgisa; D'Arena, Giovanni; Spina, Michele; Zaja, Francesco; Pozzato, Gabriele; Di Raimondo, Francesco; Rossi, Davide; Poeta, Giovanni Del; Gaidano, Gianluca; Shanafelt, Tait D; Gattei, Valter.
Affiliation
  • Bulian P; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy pbulian@cro.it.
  • Bomben R; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Bo MD; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Rossi FM; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Degan M; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Pozzo F; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Bittolo T; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Bravin V; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • D'Agaro T; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
  • Cerri M; Division of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Chiarenza A; Division of Hematology, Ferrarotto Hospital, Catania, Italy.
  • Chaffee KG; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Condoluci A; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • D'Arena G; IRCCS, Referral Cancer Center of Basilicata, Potenza, Italy.
  • Spina M; Oncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy.
  • Zaja F; Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
  • Pozzato G; Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy.
  • Di Raimondo F; Division of Hematology, Ferrarotto Hospital, Catania, Italy.
  • Rossi D; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Poeta GD; Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy.
  • Gaidano G; Division of Hematology - Department of Translational Medicine - Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Shanafelt TD; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Gattei V; Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Haematologica ; 102(11): e443-e446, 2017 11.
Article in En | MEDLINE | ID: mdl-28751560

Full text: 1 Database: MEDLINE Main subject: Trisomy / Chromosomes, Human, Pair 12 / Leukemia, Lymphocytic, Chronic, B-Cell / Genes, Immunoglobulin Heavy Chain / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Italy

Full text: 1 Database: MEDLINE Main subject: Trisomy / Chromosomes, Human, Pair 12 / Leukemia, Lymphocytic, Chronic, B-Cell / Genes, Immunoglobulin Heavy Chain / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Italy